BCV
TXMD icon

Banque Cantonale Vaudoise’s TherapeuticsMD TXMD Stock Holding History

Banque Cantonale Vaudoise’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1K Hold
7
– – ﹤0.01% 445
2026
Q1 		$0 Hold
7
– – ﹤0.01% 929
2025
Q4 		$0 Hold
7
– – ﹤0.01% 878
2025
Q3 		$0 Buy
+7
New +$8 ﹤0.01% 863
2024
Q2 		– Sell
-1,000
Closed -$2K – 1065
2024
Q1 		$2K Hold
1,000
– – ﹤0.01% 973
2023
Q4 		$2K Hold
1,000
– – ﹤0.01% 1001
2023
Q3 		$3K Hold
1,000
– – ﹤0.01% 1159
2023
Q2 		$4K Hold
1,000
– – ﹤0.01% 1145
2023
Q1 		$4K Hold
1,000
– – ﹤0.01% 1151
2022
Q4 		$6K Hold
1,000
– – ﹤0.01% 1136
2022
Q3 		$7K Hold
1,000
– – ﹤0.01% 1172
2022
Q2 		$10K Hold
1,000
– – ﹤0.01% 1186
2022
Q1 		$19K Hold
1,000
– – ﹤0.01% 1157
2021
Q4 		$18K Buy
1,000
+200
+25% +$5.99K ﹤0.01% 1194
2021
Q3 		$30K Buy
800
+200
+33% +$8.88K ﹤0.01% 1117
2021
Q2 		$36K Buy
600
+200
+50% +$12.1K ﹤0.01% 1089
2021
Q1 		$27K Hold
400
– – ﹤0.01% 1054
2020
Q4 		$24K Buy
+400
New +$27.3K ﹤0.01% 1005

Other funds holding TXMD

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
CC
Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TC
Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Banque Cantonale Vaudoise's TXMD Position: Q2 2026 in Review

Banque Cantonale Vaudoise held its TherapeuticsMD (TXMD) position steady in Q2 2026 at 7 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #445.

Banque Cantonale Vaudoise first reported a position in TXMD in Q4 2020 and has held it in 18 quarters since. The position peaked at $36K in Q2 2021. 45 funds tracked by Wall St. Rank hold TXMD as of Q2 2026.

  • Banque Cantonale Vaudoise held 7 shares of TherapeuticsMD worth $1K as of Q2 2026.
  • Banque Cantonale Vaudoise left its TherapeuticsMD share count unchanged in Q2 2026.
  • TherapeuticsMD made up ﹤0.01% of Banque Cantonale Vaudoise's portfolio in Q2 2026, its #445 holding.
  • Banque Cantonale Vaudoise first reported a position in TherapeuticsMD in Q4 2020 and has held it in 18 quarters since.
  • Banque Cantonale Vaudoise's TherapeuticsMD position peaked at $36K in Q2 2021.
  • 45 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2026.

Based on Banque Cantonale Vaudoise's 13F filing for Q2 2026, filed 31 Jul 2026.